Instruction to Authors
Aims and scopes
The Journal of Biomedicine (JBM) is a peer review quarterly journal and publishes original papers related to all areas of basic, biomedical sciences and health sciences. The journal welcomes all researchers working in the different fields of medical sciences. Manuscripts are accepted on condition that they have not been previously published or submitted for publication and are not going to be sent to other journals.
This journal defines an author as a person who has made a substantive contributions to design of the work, or to analyze or interpret of data; and to draft or revise it; and to verify the approval of the version to be published and to agree for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Those who do not meet at least one of the above criteria should be acknowledged.
Author list and their order should be finalized by all the authors prior to first submission. After this step, journal could not accept any addition or changes. One author as a corresponding author should be responsible for:
Open access agreement
Upon submitting an article, authors are asked to indicate their agreement to abide by an open access Creative Commons license (CC-BY). Under the terms of this license, authors retain ownership of the copyright of their articles. However, the license permits any user to download, print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work. The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
The manuscript should be submitted to journal office via email attachments email@example.com (alternative email: firstname.lastname@example.org) or through online submission at journal website.
Cover letter signed by the author(s) must be attached indicating the manuscripts have not been previously published or submitted for publication in other journals. Also, full name, affiliation, academic degree, postal address, telephone, fax number and email address should be indicated. On the other hand, conflicts of interest should be declared obviously in the cover letter. Before submission, registration has to be done at journal website by the corresponding author.
In the Cover Letter all of the authors must declare their agreement on submitting the manuscript to JBM, furthermore Cover Letter should identify corresponding author and his/her contact information (address, telephone and fax numbers and e-mail address)
Language and style
All submitted manuscripts should be in English. Nonnative English speakers may be advised to seek professional help with the language. All materials should be typed double line spacing numbered page with Times New Roman font (size 12). Abbreviations should be standardized and used just in necessary cases, after complete explanations at the first usage.
Types of acceptable articles
A manuscript can be classified under one of the following categories:
Preparation of manuscript
It should not exceed 7000 words and they should have the following format:
Title page: Title page of the manuscript should include the title of the manuscript; authors' names and affiliations; name of the institution/university where the work was done; and complete mailing address, telephone and email address of the corresponding author. This page should be in a separate page with no number. First character of all words in the manuscript title must be written in capital form with exception of prepositions and conjunctions words.
Abstract: A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. altogether should be in the range of 200-300 words.
Keywords: Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Introduction: Introduction should provide a background and specifies the research objective of the study or observation. This section must emphasize the purpose and the rationale for the study. It should neither review the subject extensively nor should it have data or conclusions of the study.
Methods: Materials and methods must indicate clearly the steps taken to acquire the information. It should be detailed. Repeating the details of standard techniques is best avoided. The software used for statistical analysis and description of the actual method should be mentioned.
Results & Discussion: Result and discussion cold be separate or together. Results should be presented in chronological sequence in the text, table and figure. The results should not be obtained from elsewhere. Table and illustrations have to be cited in order they appear in the text using Arabic numerals. Discussion should emphasize the new and important aspects of the study. Possible explanations for these findings should be mentioned.
Conclusion: In this section, overall conclusion of the author(s) from the research, the limitation of the work and the implications of the finding for future research should be noted.
Acknowledgment: Acknowledgments should be mentioned for any technical help or general, financial, and material support or contributions that need to be acknowledged.
References: All manuscripts should be accompanied by relevant references. The Reference should provide the following information as stated in the presented models as follows:
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct. If you do wish to format the references yourself they should be arranged according to the following examples:
Text: All citations in the text should refer to:
1. Single author: the author's name (without initials, unless there is ambiguity) and the year of publication;
2. Two authors: both authors' names and the year of publication;
3. Three or more authors: first author's name followed by 'et al.' and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999). Kramer et al. (2010) have recently shown ....'
List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of publication.
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific article. J. Sci. Commun. 163, 51–59.
Reference to a book:
Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman, New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281–304.
Reference to a website:
Cancer Research UK, 1975. Cancer statistics reports for the UK. http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/ (accessed 13 March 2003).
Reference to a dataset:
[dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T., 2015. Mortality data for Japanese oak wilt disease and surrounding forest compositions. Mendeley Data, v1. https://doi.org/10.17632/xwj98nb39r.1.
Tables: In limited numbers should be submitted with the captions placed above.Each table should be numbered consecutively with Roman numerals and typed double-spaced, including all headings. Verify tabular statistics to make sure they tally and match data cited in the text. Do not submit tables as photograph.
Figures: Should be in limited numbers, with high quality art work and mounted on separate pages. The captions should be placed below. The same data should not be presented in tables, figures and text, simultaneously.
Illustrations: Three copies of all figures or photographs should be included with the submitted manuscript. Photographs must be high-contrast, glossy, black and white prints, unmounted and untrimmed, with preferred size of 10 x 15 cm. Color transparencies or photos will be accepted at the discretion of Editorial Board. Figure number, and name of senior author, should be written on the back of each illustration. Written permission must accompany any photograph in which the subject can be identified or any illustration that has been previously published. All illustrations must be numbered as cited in the text in consecutive numeric order.
Abbreviations: Abbreviations that are unavoidable in the abstract must be defined at their first mention there. Also, abbreviations should be explained throughout the manuscript.
Clinical Trial Registration
From January 2010, all of the Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. This includes all of the clinical trials performed inside Iran even if they register in other registration sites. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O.
According to the International Committee of Medical journal Editors (ICMJE) a Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.
The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.
It should be prepared according to one of the following styles:
It can be in form of original article, systematic review or ongoing research which reports its interesting findings. The parts in this type of articles are like those of original one except that ‘Materials and methods’ section should has not any subtitle. These kinds of manuscripts are smaller and prepared in minimum 1500 and maximum 2500 words.
Letter to the editor
It should be about criticism of previous articles in this journal or the others, criticism or review over books, analysis of a related topic with community health . These manuscripts need no structure and have not abstract. But, the total words number should be at maximum 2000 including references and the references not exceeding more than 10.
This kind of manuscript should include abstract, keywords, introduction, case report, discussion, conclusion, conflicts of interest, acknowledgment, and references. Case report should have 1500-2500 words. The title should include the words ‘case report’ as well as a description of the reported phenomenon (e.g., reporting of new and emerging community health problem). Three to five key words should be provided.
These manuscripts need no structure and have not abstract. But, the total words number should be at maximum 2500 including references and the references not exceeding more than 20.
Conflicts of interest
Submitting a manuscript must be accompanied with a statement from the authors disclosing all financial and personnel relationship that might bias their work, if any. Besides, they are requested to evident whether impending conflicts do or do not exist. A separate page should cover this proclamation and if there are further details, could be mentioned in covering letter. If an organization encompasses any financial interest in the outcome of the study, the authors are appealed to provide a declaration that has full excess to all data in the study and take complete responsibility for the integrity of data and the accuracy of data analysis.
All studies must be approved by the relevant Ethics Committee/ Institution review boards of the respective institutions. Informed consent of the patients participating in the study should be undertaken. The study itself should follow the ethical standards of the Helsinki Declaration, as revised in 2013 and available at:
Ethical considerations in accordance with the ethical standards of the responsible committee on human experimentation must be addressed in the ‘Materials and methods’ section, if necessary. The journal will not consider any manuscript which is ethically unacceptable. It is the responsibility of the authors/contributors to obtain permissions for reproducing any copyrighted material. Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. The related items should be inserted under the ‘Materials and methods’ section. A copy of the permission must accompany the manuscript. As mentioned previously, conflicts of interest should be declared obviously in each manuscript.
Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged and the text is inserted in quotation mark. If there is an allegation of plagiarism, scientific misconduct or fraud, the journal will follow the recommendations of the Committee on Publication Ethics, COPE (http://publicationethics.org/) and International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/). The Journal reserves the right to report the allegations to the author’s institution or any other agency.
Once approved to be published in the journal, the manuscript cannot be published elsewhere (even local journals). The copyright form should be filled and signed by all the authors, and then scanned and emailed by corresponding author to the journal office (email@example.com).
Peer review process
Each submitted manuscript will be assessed from editorial points of view, at first. Should the manuscript meet the basic editorial requirements; it will enter the double blind peer-review process in maximum two weeks and the author(s) will be immediately informed. The manuscript will then be sent at least to one in-office and two out of office referees for review. The corresponding author will then be informed to the referee’s remark to accept, reject or require revision. Authors have the right to communicate to the editor if they do not wish their manuscript to be reviewed by a particular reviewer because of potential conflicts of interest. The corresponding author can also suggest three expert referees along with their names, affiliation, academic degree, postal address, telephone and email address but, it is up to the editor to accept it. Referees should not be from the same institution or university of the authors.
No article is rejected unless negative comments are received from at least two reviewers. The editorial board of the journal, reserves the right to accept or reject the article in any stage and any time or delete a part of the text, tables or figures, if necessary. Final decision pertaining to each manuscript, lasting up to a month at maximum, is determined by the editorial board of the journal and after that the decision will be immediately sent to the corresponding author.